CNXC
Concentrix Corporation
CNXC lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
CNXC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Healthy | |
| Under pressure |
CNXC's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
CNXC PE Valuation
CNXC has no meaningful PE right now: it lost money over the past year.
CNXC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect CNXC's earnings to grow and its profitability to improve, with its revenue holding steady.
CNXC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.51 | — |
| Q3 2026 | -$38.42 | -912% |
| Q2 2026 | -$20.84 | -673% |
| Q1 2026 | -$21.07 | -628% |
| Q4 2025 | -$20.36 | -649% |
| Q3 2025 | $4.73 | +57% |
| Q2 2025 | $3.64 | -14% |
| Q1 2025 | $3.99 | -17% |
| Q4 2024 | $3.71 | -35% |
CNXC has swung to a loss: it lost $38.42 per share over the past year, after a profit the year before.
CNXC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.5B | -1.2% |
| Q2 2026 | $2.5B | +1.9% |
| Q1 2026 | $2.5B | +5.4% |
| Q4 2025 | $2.6B | +4.3% |
| Q3 2025 | $2.5B | +4% |
| Q2 2025 | $2.4B | +1.5% |
| Q1 2025 | $2.4B | -1.3% |
| Q4 2024 | $2.4B | +9.7% |
CNXC's revenue grew through 2024 and has held roughly level since: $2.5B last quarter, down 1.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -37% | -43 points |
| Q2 2026 | 3.9% | -2.3 points |
| Q1 2026 | 4.7% | -2.4 points |
| Q4 2025 | -54% | -60 points |
| Q3 2025 | 5.9% | -0.5 points |
| Q2 2025 | 6.1% | -0.2 points |
| Q1 2025 | 7.1% | +0.9 points |
| Q4 2024 | 5.9% | -2.2 points |
CNXC's operating margin was −37% last quarter, down 43 points from the same quarter a year ago, near the bottom of its range since 2019.
CNXC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $221.2M | +38% |
| Q2 2026 | $209.7M | +16% |
| Q1 2026 | -$137.1M | -$87.9M |
| Q4 2025 | $281.2M | +25% |
| Q3 2025 | $159.7M | +24% |
| Q2 2025 | $180.7M | +1.4% |
| Q1 2025 | -$49.2M | +$53.7M |
| Q4 2024 | $224.5M | +37% |
CNXC generated $575M in free cash flow over the past year, up 11% from the year before.
CNXC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +48K shares |
| 1 year | -2.9% | -1.8M shares |
| 3 years | +19% | +9.7M shares |
| 5 years | +17% | +8.8M shares |
| Available history | +19% | +9.8M shares |
CNXC has 61M diluted shares, down 2.9% from a year ago, with $99M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $43.2M |
| Q4 2025 | $55.9M |
| Q3 2025 | $41.6M |
| Q2 2025 | $45.3M |
| Q1 2025 | $25.8M |
| Q4 2024 | $34.5M |
CNXC spent $99M buying back its own shares over the past year, down 33% from the year before.
CNXC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.9x | Elevated |
| Q4 2024 | 4.2x | High |
| Q3 2024 | 4.7x | High |
| Q2 2024 | 5.4x | High |
| Q1 2024 | 5.6x | High |
| Q4 2023 | 5.6x | High |
CNXC's net debt is about 3.5 years of its operating earnings (EBITDA), down from 4.7 years a year ago.
CNXC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.3 | Neutral |
| Stochastic | 68.9 | Neutral |
CNXC's weekly RSI is 56 (neutral) and its Stochastic is 69 (neutral).
CNXC PE vs Technology Sector
| Metric | CNXC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CNXC has no meaningful PE right now: it lost money over the past year.
CNXC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.9 | 11% above |
| 20 week MA | $27.1 | 18% above |
| 50 week MA | $30.3 | 5.7% above |
| 100 week MA | $39.7 | 19% below |
| 200 week MA | $60.0 | 47% below |
CNXC has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 47% below its 200-week average.
CNXC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $80.0 | $99.9 | +25% |
| 2021 | $99.9 | $177.2 | +77% |
| 2022 | $177.2 | $129.6 | -27% |
| 2023 | $129.6 | $98.2 | -24% |
| 2024 | $98.2 | $44.4 | -55% |
| 2025 | $44.4 | $42.0 | -5.6% |
| 2026 YTD | $42.0 | $32.0 | -24% |
CNXC has finished four years in a row lower, and it's down 24% so far in 2026.